Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort study

• Main Authors: Rachel P. Ogilvie (Author), J. Bradley Layton (Author), Patricia C. Lloyd (Author), Yixin Jiao (Author), Djeneba Audrey Djibo (Author), Hui Lee Wong (Author), Joann F. Gruber (Author), Ron Parambi (Author), Jie Deng (Author), Michael Miller (Author), Jennifer Song (Author), Lisa B. Weatherby (Author), Lauren Peetluk (Author), An-Chi Lo (Author), Kathryn Matuska (Author), Michael Wernecke (Author), Christine L. Bui (Author), Tainya C. Clarke (Author), Sylvia Cho (Author), Elizabeth J. Bell (Author), Grace Yang (Author), Kandace L. Amend (Author), Richard A. Forshee (Author), Steven A. Anderson (Author), Cheryl N. McMahill-Walraven (Author), Yoganand Chillarige (Author), Mary S. Anthony (Author), John D. Seeger (Author), Azadeh Shoaibi (Author)
• Format: Book
• Published: BMC, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background COVID-19 vaccines are authorized for use in children in the United States; real-world assessment of vaccine effectiveness in children is needed. This study's objective was to estimate the effectiveness of receiving a complete primary series of monovalent BNT162b2 (Pfizer-Bio...